MST3 is a member of the sterile-20 protein kinase family with a unique preference for manganese ion as a cofactor in vitro; however, its biological function is largely unknown. Suppression of endogenous MST3 by small interference RNA enhanced cellular migration in MCF-7 cells with reduced expression of E-cadherin at the edge of migrating cells. The alteration of cellular migration and protruding can be rescued by RNA interference-resistant MST3. The expression of surface integrin and Golgi apparatus was not altered, but phosphorylation on tyrosine 118 and tyrosine 31 of paxillin was attenuated by MST3 small interfering RNA (siRNA). Threonine 178 was determined to be one of the two main autophosphorylation sites of MST3 in vitro. Mutant T178A MST3, containing alanine instead of threonine at codon 178, lost autophosphorylation and kinase activities. Overexpression of wild type MST3, but not the T178A mutant MST3, inhibited migration and spreading in Madin-Darby canine kidney cells. MST3 could phosphorylate the protein-tyrosine phosphatase (PTP)-PEST and inhibit the tyrosine phosphatase activity of PTP-PEST. We conclude that MST3 inhibits cell migration in a fashion dependent on autophosphorylation and may regulate paxillin phosphorylation through tyrosine phosphatase PTP-PEST.
in the mating pathway of Saccharomyces cerevisiae. The mammalian Ste20 family consists of two structurally distinct subfamilies, including P21-activated kinases (PAK) and germinal center kinases (GCK). PAK regulates several critical signal pathways through the interaction with many proteins, including Rho GTPase (4, 5) . Autophosphorylation plays an important role in the activation of PAK (6, 7) .
GCK includes GCK, YSK1, and mammalian Ste20-like (MST)1-4 kinases (8) . MST1 and MST2 undergo autophosphorylation and are activated by a variety of stress stimuli (9 -11) . MST2 plays a role in suppressing RAF-1-mediated apoptosis (12) and activates the human large tumor suppressor kinase LATS1 (13) . YSK1 is activated by the Golgi matrix protein GM130 and plays a role in migration (14, 15) . MST4 enhances cell transformation and plays a role in prostate cancer progression (16 -18) . MST3 does not alter any known MAPK pathway by overexpression of either wild type MST3 or kinasedead MST3 (19) . Nuclear translocation and activation of MST3 occur during apoptosis (20) , and the nuclear translocation signal of MST3 has been determined (21) . One unique feature of MST3 is the preference for Mn 2ϩ as the cofactor in the kinase reaction, an unusual feature for a serine/threonine kinase (19) . Recently, we have further demonstrated that Zn 2ϩ is also a cofactor for MST3 (22) .
Cell migration is an important process that is essential for development and life long physiological processes (23, 24) . Migration can be viewed as a cyclical process. First, cells begin to polarize and make protrusions in response to out-side stimuli. Second, cells form adhesions that attach the protrusion to the substratum. Third, these adhesions partially act as tracking points for migration. Finally, contraction moves the cell body forward and releases the attachment through disassembly of the adhesion at the rear end, allowing the cycle to begin again.
Several types of adhesion occur in different cell types on various substrata. One type of adhesion involves integrin, a heterodimeric receptor consisting of ␣ and ␤ chains. Binding of ligand changes the interaction between the ␣ and ␤ chain cytoplasmic domains and integrin clustering (25) . Activated integrins preferentially localize to the site of new adhesion and establish interactions with several proteins, including focal adhesion kinase, paxillin, p130 Crk-associated protein (p130 CAS), and others (26 -28) . Paxillin is usually recruited to the leading edges of migrating cells, where it acts as a scaffold for protein interactions (29) , and paxillin is essential for proteintyrosine phosphatase (PTP)-PEST inhibition of cell spreading and membrane protrusion (30) . Regulation of tyrosine phosphorylation on Tyr-31/118 is observed during cell migration and adhesion (31, 32) . Replacement of Tyr-31/118 with phenylalanine reduces cell motility with reduced Crk-II association (33) , whereas coexpression of the Crk-II adaptor protein and protein-tyrosine phosphatase 1B promotes cell migration accompanying decreased tyrosine phosphorylation on paxillin (34) . Although paxillin is postulated as being a positive regular of cell migration (35) , small interference RNA (siRNA) directed against paxillin can enhance cell migration at certain circumstances (36, 37) .
In contrast to other members of the MST family, the biological functions of MST3 are less understood. RNA interference (RNAi) technology has become a powerful tool for studying protein function (38 -40) ; therefore, we investigated the altered phenotype generated by silencing the expression of MST3 with RNAi. Our results indicate that autophosphorylated MST3 inhibits cellular migration associated with alteration of paxillin phosphorylation. In addition, MST3 can phosphorylate PTP-PEST and inhibit its phosphatase activity, which may account for the change of paxillin phosphorylation.
MATERIALS AND METHODS
Cell Culture and Antibodies-MCF-7 and MDCK cells were maintained at 37°C and 5% CO 2 in defined minimal essential medium (DMEM) supplemented with 10% fetal calf serum (DMEM/FCS). MDA-MB-231 cells were grown in Leibowitz's L15 medium, supplemented with 14 mM NaHCO 3 and 10% fetal calf serum. MCF-10A cells were kindly provided by Dr. MienChie Hung and cultured in DMEM/F-12 medium containing 5% equine serum, 0.5 g/ml Fungizone, 10 g/ml insulin, 20 ng/ml epidermal growth factor, and 0.5 g/ml hydrocortisone. Antibodies utilized were anti-GM130 Ab (610822; BD Transduction Laboratories), anti-paxillin (610052; BD Transduction Laboratories), anti-cadherin antibody (610920;BD Transduction Laboratories), Alexa 488 goat anti-mouse IgG (A-11001; Molecular Probes, Inc., Carlsbad, CA), anti-paxillin-PY118 Ab (44-720G; BIOSOURCE), and anti-paxillin-PY31 (44-722G; BIOSOURCE). Anti-MST3 antiserum was prepared as described before (20, 22) .
RNA Interference-siRNA targeting MST3 was constructed within pHsU6 vector as described previously (40, 41) . The target sequence of MST3 was 5Ј-GGAGAAGAGCCAG-GCGTGC-3Ј (nucleotides 1127-1145 of MST3 from the start codon). Cells were cotransfected with the pHsU6 vectors containing shRNA of targeting sequences and pCMV-neo by using Lipofectamine 2000 transfection reagent (Invitrogen). The stable transfectants were selected with G418. To monitor the efficacy of MST3-RNAi, the expression of MST3 in MCF7 stable transfectants was analyzed by Western blotting and probed with anti-MST3 antiserum.
MST3 Mutant Plasmids-Wild type HA-MST3 and the indicated mutants were constructed between NotI and EcoRI sites in pcDNA3.0 with HA epitope tags added to the N terminus. PCR-directed mutagenesis was used to achieve the desired mutations. The primers for MST3 T178A were as follows: forward primer, 5Ј-CAAAAGGGCCTTCTTCGT-GGGC-3Ј; reverse primer, 5Ј-GCCCACGAAGAAGGCCCT-TTTG-3Ј. The primers for MST3 T264A were as follows: forward primer; 5Ј-CTTTAGACCCGCTGCTAAGGAGTT-3Ј; reverse primer, 5Ј-AACTCCTTAGCAGCGGGTCTAAAG-3Ј. The underlined base pairs represent the mutated amino acids. The sequence altered in RNAi-resistant MST3 is GGA-GAAAAGCCAAGCTTGC (nucleotides 1127-1145) without altering the amino acid sequence. All mutant MST3 plasmids were confirmed by DNA sequencing.
Wound-healing Assays-Cells were plated onto glass-based dishes coated with 10 g/ml fibronectin (FN) at a saturation density (1.2 ϫ 10 6 cells/35-mm diameter). Cells were then scratched manually with a blade 24 h after plating. The wounded regions were allowed to heal for a defined time in DMEM/FCS. Images for these cells were observed by phasecontrast microscopy using a CKII microscope (Olympus, Japan).
Migration Assays-Cells were cultured to confluence in DMEM/FCS. The lower compartment of a Boyden chamber was filled with 1 g/ml FN (26 l/well), and 5 ϫ 10 5 /ml cells in serum-free medium were added to the upper compartment of the chamber (50 l/well). The chambers were separated by a polycarbonate filter (25 ϫ 80 mm, 8 m pore size, polyvinylidene difluoride; GE Osmonics, Trevose, PA). The cells were allowed to migrate for a defined time at 37°C in a humidified atmosphere containing 5% CO 2 . Nonmigrated cells remaining on the upper surface of the filter were removed mechanically by scraping with a cotton swab. Cells that had migrated through the pores were fixed in methanol for 8 min and then stained with 10% Giemsa stain-modified solution (Fluka, Buchs, Switzerland). Cells were examined and counted with U-5RE-2 microscope (Olympus, Japan).
Immunoprecipitation and in Vitro Kinase Assay-Cells were washed three times with cold phosphate-buffered saline (PBS) and then lysed using 300 l of lysis buffer containing 150 mM NaCl, 50 mM NaH 2 PO 4 ⅐2H 2 O, 6 mM deoxycholate, 1% Igepal-Ca-630 (Sigma), 1 mM sodium orthovanadate, 2 mM EGTA, 0.5% aprotinin (Sigma), and 1 mM phenylmethylsulfonyl fluoride. After a 15-min centrifugation at 8000 rpm, supernatant containing 300 g of total proteins was incubated for 2 h at 4°C with 1 g of anti-HA or Mg 2ϩ at room temperature for 20 min. The reaction was stopped by the addition of 6 l of 10ϫ SDS loading buffer. After boiling for 5 min, proteins in the kinase reactions were separated by SDS-PAGE. The gel was dried, and substrate phosphorylation was visualized by autoradiography.
In Vitro Kinase Assay with Protein-tyrosine Phosphatase-0.5 g of recombinant MST3 was incubated with 1 g of recombinant PTP1B (amino acids 1-321) enzyme (Exalpha Biologicals), 0.5 g of myelin basic protein, or 0.5 g of recombinant PTP-PEST (amino acids 2-300) enzyme (Exalpha Biologicals) in kinase buffer described as above. Kinase reactions were performed at room temperature for 15 min and stopped by the addition of 6 l of 10ϫ SDS loading buffer.
MST3 33 P incorporated into a given amount of synthetic peptide was quantified by spotting the phosphorylated peptide on P81 paper and counting the radioactivity in a Cerenkov counter. Kinetic parameters were determined by varying the concentration of peptide from 0.4 to 2.4 mM while maintaining the ATP concentration at 10 M.
Phosphopeptide Analysis-MST3 (178) peptide (25 g), Histagged recombinant MST3 (1 M), or both were incubated in a 25-l reaction mixture containing 0.2 mM [␥- labeled T178 peptide (ϳ3,000 cpm), 32 P-autophosphorylated MST3 (ϳ3,000 cpm), or both 32 P-labeled MST3 (178) peptide (ϳ1,500 cpm) and 32 P-autophosphorylated MST3 (ϳ1,500 cpm) were subjected to two-dimensional phosphopeptide map analysis as described before (42) . The samples were analyzed in the first dimension on cellulosecoated TLC plates (Merck) in a solution (formic acid/acetic acid/water, 50:156:1794 by volume) at 1 kV for 40 min followed by ascending chromatography in the second dimension in a solution (butanol-1/pyridine/acetic acid/water, 15:10:3:12 by volume) for 6 -8 h. The air-dried plates were exposed to x-ray films for autoradiography.
Immunofluorescence MicroscopyCells were plated on 10 g/ml fibronectin-coated glass-based dish. Cells were then fixed with 3.7% paraformaldehyde in PBS for 20 min and permeabilized with 0.1% Triton X-100 in PBS. The permeabilized cells were washed three times with PBS and then incubated with anti-GM130, anti-paxillin, and anti-cadherin antibody. Alexa 488 goat antimouse IgG was used to visualize proteins. Images for these proteins were obtained by fluorescent microscopy (NIKON 80I fluorescence microscope, Japan) or confocal microscopy (LSM510 Pascal, Carl Zeiss, Germany).
Cell Sorting with Flow CytometryCells were cotransfected with the indicated plasmids and pEGFP-N1 plasmid (Clontech) by Lipofectamine 2000 transfection reagent (Invitrogen). Twenty four hours after transfection, cells were mechanically dissociated to obtain a single cell suspension in a solution containing 2% bovine serum albumin in PBS. Cells were harvested by centrifugation (1500 rpm, 5 min, 4°C), filtered through a 0.35-m filter (Falcon), and kept on ice until FACS analysis. Cell sorting was performed on a FACSAria flow cytometer (BD Biosciences) equipped with 488-nm argon and 633-nm He-Ne lasers. The green fluorescent protein-expressing cells were seeded on a FN-coated dish to observe cell protrusion or sorted for analysis with Boyden chamber migration assay.
Protein-tyrosine Phosphatase Activity-PTP-PEST activity was measured by using 6,8-difluoro 4-methylumbelliferyl phosphate (Molecular Probes, Eugene, OR). Cells were lysed on ice with 0.5% aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, and 50 mM Tris, pH 7.4. Cell lysate was centrifuged at 4°C and 1000 ϫ g for 10 min. The supernatant was subjected to immunoprecipitation with PTP-PEST antibody (AG10, Cell Signaling). The immunoprecipitated PEST was added to the substrate-coated assay wells. Samples were incubated for 1 h, and phosphatase activity was determined by using a fluorimeter at an excitation/emission wavelength of 358/452 nm. The PTP-PEST plasmid was purchased from OriGene Technologies Inc.
Statistical Analysis-All the statistical analyses were performed with Student's paired t test.
RESULTS

Establishment of MST3-RNAi
Transfectants-To investigate the biological function of MST3, we constructed U6 promoter plasmidbased shRNA targeting at nucleotides 875, 1127, and 1170 on the MST3 gene. The efficacy of the three shRNA-MST3 constructs was determined by cotransfection of the shRNA and HA-MST3 expression plasmids into COS-1 cells. The shRNA targeting at nucleotide 1170 had no effect, whereas the shRNA targeting nucleotide 1127 was the best among the three, inhibiting more than 90% of HA-MST3 expression (data not shown). The MCF-7 breast cancer cell line was cotransfected with the plasmid expressing shRNA against MST3 and a neomycin marker. Two stable clones (RNAi-1 and RNAi-2) were established by selection with G418. The other two stable clones (vector-1 and vector-2) had no shRNA integration. The expression of endogenous MST3 of RNAi-1 or RNAi-2 cells was less than 20% of control transfectants or MCF-7 parental cells (Fig. 1A) . The growth rates of MST3-RNAi transfectants were similar to that of parental cells and control transfectants (data not shown).
Down-regulation of MST3 Enhanced Cell Migration-Because YSK1, a member of MST family, played a role in cellular migration (14) , we further examined whether MST3 affected cellular migration. A wound-healing assay was performed to monitor cell migration. Cell migration toward the wound was recorded at 24 and 72 h after scratching. MST3 RNAi transfectants migrated faster than control transfectants (Fig. 1B) . Decreased expression of E-cadherin and loss of cellular contacts is usually observed at the migrating cell edge in collec- tive cell migration (36) . The expression of E-cadherin was much lower in the leading cell edges of MST3 RNAi transfectants (Fig.  1C, lower panel) . Conversely, the expression of E-cadherin in the center of the cell mass was not significantly altered between MST3 RNAi and control transfectants (Fig. 1C, upper panel) .
In addition to the wound-healing assay for measuring collective cell migration (36), Boyden chamber assay was used to assess the cell migration without cell-cell interaction (Fig. 1D) . Both RNAi transfectants displayed a significant enhancement of cell migration than control transfectants.
Effect of Down-regulation of MST3 on Paxillin Phosphorylation and Cellular Protruding-The expression of integrins ␣3 and ␤1 was not altered by the expression of MST3 siRNA (data not shown). Antibody to activated integrin (conformation-specific antibody for ␤44) did not produce a significant difference upon flow cytometric analysis (data not shown). In contrast, decreased phosphorylation on residue 118 on paxillin was evident on MST3 RNAi transfectants at 24 or 48 h after plating (Fig. 2, A and B) . A minor decrease of phosphorylation of Tyr-31 on paxillin was observed in MST3 RNAi transfectants. To assess if the altered paxillin phosphorylation was associated with change of distribution for MST3 RNAi transfectants, cells were plated for 24 h, and the localization of paxillin was determined using an immunofluorescence analysis. Paxillin formed speckles on one edge of the MST3 RNAi transfectants (Fig. 2C) . However, the distribution of paxillin in RNAi transfectants was not altered in the spread cells. The RNAi transfectants spread faster than the control transfectants, and the percentage of protruded cells was determined in triplicate experiments (Fig. 2D) . Because YSK1 might affect Golgi distribution, we examined the GM130 distribution in RNAi transfectants. The GM130 distribution was not altered in the transfectants (data not shown).
The Enhancement of Cell Migration and Protruding Can Be Rescued by RNAi-resistant MST3-
To further examine the specificity of MST3 siRNA, we performed the rescue assay with RNAi-resistant HA-MST3 (Rnai-R-HA-MST3). Three nucleotides of wild type MST3 were mutated to create resistance to shRNA-MST3 siRNA, and the encoding protein was not altered. The shRNA-MST3 could only weakly degrade the RNAi-resistant HA-MST3 in transiently transfected COS-7 cells (Fig. 3A, right panel) . The MCF-7-Rnai-2 cells were further transfected with pcDNA3.0, HA-MST3, or Rnai-R-HA-MST3 plasmid and examined for the expression of HA-tagged MST3. The expression of HA-MST3 was only detected in cells transfected with Rnai-R-HA-MST3 (Fig. 3A, left panel) . The protruding rate of MCF-7-Rnai-2 cells expressing Rnai-R-HA-MST3 was significantly lower than that of the pcDNA3.0 plasmid transfectants (Fig. 3B) . This indicated that the RNAiresistant MST3 could rescue the enhancement of spreading by shRNA-MST3 in MCF-7-Rnai-2 cells. The transfected cells were further sorted by flow cytometry and analyzed for cell migration. Reintroduction of Rnai-R-HA-MST3 significantly attenuated the enhancement of cellular migration (Fig. 3C) . Reexpression of RNAi-resistant HA-MST3 in the MCF-7-Rnai-2 cells recovered the migration speed to a similar level of the MCF-7-V-2 cells (Fig. 1D and Fig. 3C ), which suggested the RNAi-resistant MST3 can rescue the migratory phenotype induced by shRNA-MST3.
Autophosphorylation of Thr-178 in MST3-
To further understand the structure-function relationship of MST3, we identified the MST3 autophosphorylation site. When the amino acid sequence between kinase subdomain VII (DFG) and VIII (APE) of the Ste20 kinase family members was aligned (Fig.  4A) , the sequences around the Thr-178 of MST3 were determined to be essentially identical to those of other members of Ste20 family. This raised the possibility that Thr-178 in this loop was the autophosphorylation site for MST3. Another threonine (Thr-264) located outside the potential activation loop was chosen as a comparison. G peptide, the substrate for cAMPdependent protein kinase (43) , was used as the negative control, (Fig. 4C ). Based on a Lineweaver-Burk reciprocal plots, the calculated apparent K m was 1 mM, and the V max was ϳ31.2 pmol/ min/mg when Mn 2ϩ was used as the cofactor for MST3. As there are multiple serine and threonine residues in peptide 178, the phosphorylated peptide 178 was subjected to mass spectrometry analysis. Thr-178 was detected as the single phosphorylation site (Fig. 5A) . Peptide T178A containing alanine instead of threonine at position 178 was examined with kinase reaction by MST3. Peptide T178A could not be phosphorylated by MST3 (Fig. 5B ). To further demonstrate that Thr-178 was the main autophosphorylation of MST3, tryptic digests of autophosphorylated baculovirus-expressed MST3 (22) were subjected to two-dimensional electrophoresis, and the presence of two radioactively labeled phosphopeptides was detected. One of these two peptides overlapped with peptide T178 (Fig. 5C ), indicating that Thr-178 was one of the two main MST3 autophosphorylation sites.
Role of Thr-178 Autophosphorylation in Mammalian CellsTo determine the role of Thr-178 autophosphorylation of MST3 in vivo, Thr-178, Thr-264, or both in MST3 were mutated to alanine. COS-1 cells were transfected with the above HA-tagged MST3 expression constructs, immunoprecipitated with anti-HA antibody, and subjected to the in vitro kinase assays with Mn 2ϩ as cofactor. Mutant T178A MST3 exhibited a very low level of autophosphorylation activity and had very low kinase activity in the presence of Mn 2ϩ . In contrast, T264A mutant retained autophosphorylation and kinase activities. Autophosphorylated MST3 showed an additional shifted band when the immunoprecipitates were subjected to Western blotting (Fig. 6A) .
To further define the role of Thr-178 in MST3-regulated migration, fast-migrating cell line MDCK cells were selected for , and the phosphorylation site of peptide178 was analyzed by liquid chromatography/mass spectrometry. B, nonphosphorylation of peptide T178A by MST3. Peptide T178A, whose Thr-178 was changed to alanine, was subjected to kinase reaction with recombinant MST3. C, comparison of the tryptic phosphopeptide pattern derived from 32 P-autophosphorylated MST3 and 32 P-labeled peptide 178. The T178 peptide, His-tagged recombinant MST3, or both were reacted in a kinase buffer containing [␥-32 P]ATP. The reaction product was separated in 16.5% SDS-PAGE and isolated. The isolated products were digested with trypsin and subjected to two-dimensional phosphopeptide map analysis. Ori, origin. The 32 P-spot denoted by an arrow represents the major phosphopeptide commonly detected in each map. , T178A/T264A-MST3, T178A-MST3, or T264A-MST3 , respectively, and immunoprecipitated (IP) with anti-HA antibody. The immunoprecipitates were assayed for kinase activity with myelin basic protein and Mn 2ϩ as the cofactor. Radiolabeled samples were resolved by 15% SDS-PAGE followed by autoradiography. The radiolabeled samples were also subjected to 8% SDS-PAGE and probed with anti-MST3 antibody. IB, immunoblot. B, influence of WT-MST3 or T178A-MST3 expression on cell migration in MDCK cells. MDCK cells stably expressing WT-MST3 or T178A MST3 were subjected to wound-healing assay, and cells were photographed 12 and 24 h later. C, the longest migration distance in wound-healing assay was quantitated in three independent experiments. D, migration of various MST3 MDCK transfectants in Boyden chamber assay. Cells were plated on the membranes of the chambers in the serum-free medium in the wells, fibronectin as chemoattractant, and the migrated cells were calculated 7 h after plating. ** represents p Ͻ 0.01, and *** represents p Ͻ 0.001 when compared with control MDCK cells. target cells. MDCK cells were transfected with either wild type MST3 or T178A MST3 and selected for stable clones. The wound-healing assay revealed that the collective migration rate of MST3 stable transfectants was lower than parental MDCK cells, whereas the migration rates of MDCK-T178A-MST3 stable clones are higher than that of MDCK cells (Fig. 6B) . Quantitation and statistical analysis of the longest migration distance in three independent experiments were shown in Fig. 6C . Expression of wild type MST3 also significantly inhibited the cell migration with Boyden chamber assay, whereas T178A mutant MST3 could significantly enhance cell migration (Fig.   6D ). The growth rates of MDCK-MST3 and MDCK-T178A-MST3 transfectants were similar (data not shown).
Cell protrusion was also compared among these mutant MST3 transfectants at 1, 2, and 24 h after seeding the cells onto the plates coated with fibronectin (Fig. 7A) . All cells completely protruded at 24 h. MST3 apparently inhibited protrusion, whereas the T178A MST3 enhanced protruding. The percentage of protruded cells were calculated (Fig. 7B) . We further examined paxillin phosphorylation among the MST3 mutants. Expression of wild type MST3 increased Tyr-118 and Tyr-31 phosphorylation of paxillin (Fig. 7C) , whereas expression of T178A MST3 decreased Tyr-118 and Tyr-31 phosphorylation. The quantitations of paxillin phosphorylation in three independent experiments were shown in Fig. 7D .
MST3 Phosphorylates PTP-PEST-MST3 is a kinase involved in phosphorylation at serine or threonine residues, and so is unlikely to directly change the tyrosine phosphorylation of paxillin. Therefore, we hypothesized that MST3 may act through protein-tyrosine phosphatases to alter paxillin phosphorylation. PTP-1B and PTP-PEST were known to affect paxillin phosphorylation (30, 34) and were tested as MST3 substrates. Recombinant MST3 can directly phosphorylate recombinant PTP-PEST but was unable to phosphorylate PTP-1B in vitro (Fig. 8A) . MDCK cells were cotransfected with PTP-PEST expression plasmid and MST3 expression plasmid, and the tyrosine phosphatase activity of immunoprecipitated exogenous PTP-PEST was measured. MST3 inhibited the protein-tyrosine phosphatase activity of PTP-PEST and raised paxillin phosphorylation (Fig. 8B) . Furthermore, the protein-tyrosine phosphatase activity of PTP-PEST was enhanced in MCF7-Rnai-2 cells (Fig. 8C) .
MST3 Kinase Activity in Breast Cancer Cell Lines-Finally, we wished to study the status of MST3 in immortalized MCF-10A cells, poorly metastatic MCF-7, and highly metastatic MDA-MB-231 cancer cell lines. The expression of MST3 was similar among the three breast cell lines (Fig. 9A) . Recently, MST3 has been shown to regulate NDR protein kinase through phosphorylation (44) . The immunoprecipitated MST3 kinase activity toward the NDR peptide was not significantly different among these three cell lines. On the other hand, the MST3 kinase activity toward peptide T178 was varied among these cell lines (Fig. 9B ).
DISCUSSION
We demonstrate that MST3 regulates cellular migration with alteration of PTP-PEST activity and paxillin phosphorylation. Either overexpression or downregulation of MST3 affects cellular protrusion and migration. The effects of MST3 on cellular migration are dependent on its autophosphorylation. Mutation of the autophosphorylation site of MST3 inactivates the observed effect on cellular migration. Altogether, we conclude that autophosphorylated active MST3 inhibits cellular migration.
Golgi apparatus is positioned at the edge of wounds and both migrating and polarized cells. MST4 and YSK1 have been reported to play a role in cellular migration through targeting Golgi (14) . Cdc42, a master regulator of cellular polarity, binds to an MST3 homologue PAK4, and the binding is involved in the translocation of PAK4 to Golgi apparatus (45) . On the other hand, MST3 may affect protrusion and migration through a different pathway, because we presently observed that MST3 does not localize to Golgi, and ablation of MST3 does not affect Golgi distribution during protrusion.
Tyrosine phosphorylation of paxillin is required for the temporal regulation of focal adhesion formation in motile cells. Phosphorylation of residues 31 and 118 of paxillin occurs in cell adhesion, polarization, and migration in lymphoid cells, hepatoma MM1 cells, and NMuMG cells (31, 46, 47) . On the other hand, phosphorylation-null mutation, in which Tyr-31, -40, -118, or -181 of paxillin is mutated to phenylalanine, enhances migration activity in COS-7, NMuMG, or MM1 cells on collagen-coated dishes (48) . In addition, aberrant large protrusion and increased migration are induced by suppression of paxillin with siRNA (36) . We observed that down-regulation of MST3 enhances cellular migration with a decrease of tyrosine phosphorylation on paxillin. Similar discrepancy was also observed for another paxillin adaptor molecule PTP-PEST. Either overexpression or inactivation of PTP-PEST inhibits cell motility (49 -51) , suggesting that the balanced coordination of multiple gene products rather than the expression level or tyrosine phosphorylation of a single gene controls cellular motility.
Phosphorylation of paxillin 31 and 118 is highly inducible upon integrin activation (31) . We observed that knockdown of MST3 did not apparently affect the expression level of integrin ␣3 and ␤1 and only slightly affected the active form of integrin ␤1. Another receptor for fibronectin, integrin ␣v␤3, was not determined, because integrin ␤3 expression is FIGURE 7-continued not detected in MCF7 (52) . Integrin signaling may not be the main pathways that MST3 involved in migration. In contrast, we demonstrated that MST3 directly phosphorylated PTP-PEST but not PTP-1B. The enhancement of PTP-PEST activity in MST3 RNAi transfectants may account, at least in part, for the decrease of paxillin phosphorylation. However, MST3 may regulate cell migration through other pathways in addition to PTP-PEST. MST3 can regulate NDR protein kinase by phosphorylation (44) , and the NDR protein can regulate cell cycle progression and morphology. MST3 may act through both NDR and PTP-PEST to regulate cellular morphology and migration. In addition, it was interesting to note that ligand/hormone or endogenous stimuli for activation of NDR have not been identified (44) . Similarly, attempts to identify the stimulus for MST3 have failed (19, 20) . PTP-PEST is a potential substrate for MST3; therefore, the stimuli associated with cellular migration and PTP-PEST may be the potential ligands for MST3, such as vascular injury, CD2 in T-cell activation, and insulin-like growth factor-1 (53) (54) (55) . Investigation of these stimuli may further reveal the physiologic role of MST3. In an initial attempt to analyze the MST3 kinase activity in three different breast cancer cell lines with varied metastatic ability, we did not find the correlation between the status of MST3 and migration potential of individual cell lines. It is possible that posttranslational modification of MST3 or its interacting partners may further refine the physiological roles of MST3 in vivo. MST3 is activated by autophosphorylation (19) ; however, the site and the function in vivo have not been demonstrated before. In this study, we have identified Thr-178 as one of the major autophosphorylation sites, and mutation of this residue inactivates the MST3 kinase activity in vitro and effects on migration in vivo. Previously, several autophosphorylation sites, including Thr-183 and Thr-187, have been identified in MST1 (10) . Mutation of these two residues may cause autophosphorylation at other sites. In contrast, Thr-178 is critical for MST3 function. Mutation of the single residue almost completely inactivates its function and phosphorylation on other sites, at least in the MDCK cell line we tested. However, we do not exclude the possibility that MST3 may autophosphorylate itself at sites other than Thr-178 in other cell types or under different stimuli. Mutation on Thr-178 appears to influence the rate of migration and spreading, which may affect many physiological processes. For example, at the wound sites of gastric mucosa, cells initially spread rapidly and migrate into the lesion without proliferation (56) . This repairing process may be impaired by the expression of T178A MST3. To further investigate the role of these mutations and the physiological role of MST3, transgenic mice for MST3 will be used to study the physiological function of various forms of MST3 in our laboratory.
In summary, MST3 regulates cell migration involving paxillin and PTP-PEST. Furthermore, Thr-178 is an important autophosphorylation site of MST3; mutation of this site inactivates the migration regulatory function of MST3.
